1. Home
  2. INDP vs MDJH Comparison

INDP vs MDJH Comparison

Compare INDP & MDJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • MDJH
  • Stock Information
  • Founded
  • INDP 2000
  • MDJH 2002
  • Country
  • INDP United States
  • MDJH United Kingdom
  • Employees
  • INDP N/A
  • MDJH N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • MDJH Real Estate
  • Sector
  • INDP Health Care
  • MDJH Finance
  • Exchange
  • INDP Nasdaq
  • MDJH Nasdaq
  • Market Cap
  • INDP 12.1M
  • MDJH 9.8M
  • IPO Year
  • INDP N/A
  • MDJH 2019
  • Fundamental
  • Price
  • INDP $1.13
  • MDJH $0.18
  • Analyst Decision
  • INDP Strong Buy
  • MDJH
  • Analyst Count
  • INDP 2
  • MDJH 0
  • Target Price
  • INDP $8.50
  • MDJH N/A
  • AVG Volume (30 Days)
  • INDP 305.3K
  • MDJH 14.0M
  • Earning Date
  • INDP 11-12-2024
  • MDJH 01-01-0001
  • Dividend Yield
  • INDP N/A
  • MDJH N/A
  • EPS Growth
  • INDP N/A
  • MDJH N/A
  • EPS
  • INDP N/A
  • MDJH N/A
  • Revenue
  • INDP N/A
  • MDJH $114,849.00
  • Revenue This Year
  • INDP N/A
  • MDJH N/A
  • Revenue Next Year
  • INDP N/A
  • MDJH N/A
  • P/E Ratio
  • INDP N/A
  • MDJH N/A
  • Revenue Growth
  • INDP N/A
  • MDJH 289.97
  • 52 Week Low
  • INDP $1.03
  • MDJH $0.14
  • 52 Week High
  • INDP $3.10
  • MDJH $1.90
  • Technical
  • Relative Strength Index (RSI)
  • INDP 42.20
  • MDJH 27.57
  • Support Level
  • INDP $1.11
  • MDJH $0.16
  • Resistance Level
  • INDP $1.31
  • MDJH $0.33
  • Average True Range (ATR)
  • INDP 0.10
  • MDJH 0.04
  • MACD
  • INDP -0.01
  • MDJH -0.00
  • Stochastic Oscillator
  • INDP 14.34
  • MDJH 6.24

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About MDJH MDJM LTD

MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.

Share on Social Networks: